Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Texas Biomedical Research Institute financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Revenue

$54.9 M

FY, 2018

CreditSafe Score

?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2016FY, 2017FY, 2018
Revenue51.4M58.6M54.9M
Revenue growth, %14.0%-6.3%
Operating expense total58.0M63.0M66.0M
Depreciation and amortization6.9M7.3M7.2M
EBIT(6.7M)(4.4M)(11.1M)
EBIT margin, %-13.0%-7.5%-20.3%
Investment income6.1M2.4M(9.1M)
Net Income(6.8M)(986.4K)(28.2M)

Footer menu